AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Pietersz, GA Sandrin, MS Ling, S Li, YQ McKenzie, IFC
Citation: Ga. Pietersz et al., LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival, TRANSPL IMM, 9(1), 2001, pp. 7-11

Authors: Pietersz, GA Li, WJ Apostolopoulos, V
Citation: Ga. Pietersz et al., A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway, VACCINE, 19(11-12), 2001, pp. 1397-1405

Authors: Pietersz, GA Apostolopoulos, V McKenzie, IFC
Citation: Ga. Pietersz et al., Generation of cellular immune responses to antigenic tumor peptides, CELL MOL L, 57(2), 2000, pp. 290-310

Authors: Vaughan, HA Ho, DWM Karanikas, V Sandrin, MS McKenzie, IFC Pietersz, GA
Citation: Ha. Vaughan et al., The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan, VACCINE, 18(28), 2000, pp. 3297-3309

Authors: Apostolopoulos, V Barnes, N Pietersz, GA McKenzie, IFC
Citation: V. Apostolopoulos et al., Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses, VACCINE, 18(27), 2000, pp. 3174-3184

Authors: Pietersz, GA Li, WJ Osinski, C Apostolopoulos, V McKenzie, IFC
Citation: Ga. Pietersz et al., Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1, VACCINE, 18(19), 2000, pp. 2059-2071

Authors: Apostolopoulos, V Pietersz, GA Gordon, S Martinez-Pomares, L McKenzie, IFC
Citation: V. Apostolopoulos et al., Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway, EUR J IMMUN, 30(6), 2000, pp. 1714-1723

Authors: Apostolopoulos, V Pietersz, GA McKenzie, IFC
Citation: V. Apostolopoulos et al., Studies of MUC1 peptides, MED INTEL U, 24, 2000, pp. 106-120

Authors: Apostolopoulos, V McKenzie, IFC Pietersz, GA
Citation: V. Apostolopoulos et al., Generation of MUC1 cytotoxic T-cells in mice and epitope mapping, METH MOL B, 125, 2000, pp. 455-462

Authors: Panousis, C Pietersz, GA
Citation: C. Panousis et Ga. Pietersz, Monoclonal antibody-directed cytotoxic therapy - Potential in malignant diseases of aging, DRUG AGING, 15(1), 1999, pp. 1-13

Authors: Han, WR Murray-Segal, LJ Gershenzon, A Zhang, JG Hodder, AN Pietersz, GA Mottram, PL
Citation: Wr. Han et al., Idarubicin-145-2C11-F(ab ')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts, TRANSPL IMM, 7(4), 1999, pp. 207-213

Authors: Vaughan, HA Ho, DWM Karanikas, VA Ong, CS Hwang, LA Pearson, JM McKenzie, IFC Pietersz, GA
Citation: Ha. Vaughan et al., Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates, VACCINE, 17(20-21), 1999, pp. 2740-2752

Authors: Mottram, PL Han, W Murray-Segal, L Pietersz, GA McKenzie, IFC
Citation: Pl. Mottram et al., Idarubicin-anti-CD3 reduces vascular disease in mouse cardiac allografts, TRANSPLAN P, 31(1-2), 1999, pp. 1414-1415
Risultati: 1-13 |